Table of Contents
<< Previous Issue | Apr 2004 (Vol: 2004, Issue: 46) | Next Issue >> |
- Section: Company Profile
-
Eisai Co. Ltd
- Section: Distribution & Marketing
-
Mayne to Market Paxene® in the EU
- Section: Licensing
-
Neurocrine Acquires Wyeth’s Financial Interest in Indiplon
-
Serono and InDex in Ulcerative Colitis Deal
- Section: Mergers & Acquisitions
-
Yamanouchi and Fujisawa Strive for Global Mega-Player Status with Merger Agreement
-
Fisher Scientific to Buy Oxoid and Dharmacon for US$410 M
- Section: Research & Development
-
Chiron and Xoma to Develop Anticancer Antibodies